IP Verse

Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs

Patent No. EP3127551 (titled "Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs") was filed by Boehringer Ingelheim on Dec 28, 2006. The application was issued on Jul 29, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELANCOApr 29, 2021POTTER CLARKSON
CEVA SANTE ANIMALEApr 27, 2021CABINET BECKER ET ASSOCIES
LABORATORIOS HIPRASep 15, 2020GRUNECKER PATENT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3127551

BOEHRINGER INGELHEIM
Application Number
EP16185663A
Filing Date
Dec 28, 2006
Status
Granted And Under Opposition
Jun 26, 2020
Publication Date
Jul 29, 2020
External Links
Slate, Register , Google Patents